Showing results (271-280 of 5,669) with videos related to
Sort By:
Pageof 567
The Oncologist|May 10, 2018
Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use ProgramChiara Cremolini, Daniele Rossini, Erika Martinelli, et al.The Oncologist|July 1, 2018
Fear of Mastectomy Associated with Delayed Breast Cancer Presentation Among Ghanaian WomenYehoda M Martei, Verna Vanderpuye, Beth A JonesThe Oncologist|April 21, 2018
Recent Advances in the Treatment of Peripheral T-Cell LymphomaKamel Laribi, Mustapha Alani, Catherine Truong, et al.The Oncologist|August 5, 2018
Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing CriteriaKelsey H Natsuhara, Katya Losk, Tari A King, et al.The Oncologist|August 4, 2018
Alternate Endpoints for Phase II Trials in Advanced Neuroendocrine TumorsHiroshi Imaoka, Mitsuhito Sasaki, Hideaki Takahashi, et al.The Oncologist|August 4, 2018
Tumor Molecular Testing Guides Anti-PD-1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair VariantsShyam A Patel, Teri A Longacre, Uri Ladabaum, et al.The Oncologist|August 8, 2018
Multilevel Factors Affecting Time to Cancer Diagnosis and Care Quality in BotswanaCarolyn A Brown, Racquel E Kohler, Oaitse John, et al.The Oncologist|August 8, 2018
Pretreatment 18F-FDG Uptake Heterogeneity Predicts Treatment Outcome of First-Line Chemotherapy in Patients with Metastatic Triple-Negative Breast CancerChengcheng Gong, Guang Ma, Xichun Hu, et al.The Oncologist|August 8, 2018
Strategies for Recognizing and Managing Immune-Mediated Adverse Events in the Treatment of Hodgkin Lymphoma with Checkpoint InhibitorsSantosha Vardhana, Kara Cicero, Moises J Velez, et al.The Oncologist|August 8, 2018
Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell ChondrosarcomaAnnemiek van Maldegem, Anthony P Conley, Piotr Rutkowski, et al.Pageof 567